Hibit-rbd System

The key analytical step is interpreting light as a quantitative proxy for the amount of RBD-containing complex formed. HiBiT attached to the RBD contributes one luciferase component, while LgBiT supplies the complementary component. Association restores NanoLuc activity, so differences in luminescence can be used to compare molecular interaction levels across experimental conditions.

Different RBD variants may produce different levels of molecular association with the interaction partner being studied. The system converts these differences into measurable luminescence values because complex formation controls reconstitution of NanoLuc activity. Comparing the resulting signals supports quantitative evaluation of relative binding behavior among RBD variants in the same research framework.

An antibody or other inhibitor can be evaluated by determining whether it disrupts the interaction mediated by the RBD. If complex formation decreases, the corresponding NanoLuc-derived luminescence can provide evidence of reduced association. This makes the platform useful for comparing how effectively different blocking molecules interfere with RBD-dependent molecular interactions.

A basic experiment brings together the RBD fused to HiBiT and its complementary LgBiT fragment, then examines the resulting luminescence under the interaction condition of interest. Receptor engagement, RBD variants, antibodies, or other inhibitors can be incorporated as the experimental comparison. The measured light provides the quantitative outcome for assessing complex formation.

Researchers can use the platform when they need to examine how a viral spike-protein RBD engages a receptor or how that engagement changes among variants. Because the assay produces a measurable luminescent readout, it supports quantitative studies relevant to viral entry without limiting the analysis to a purely qualitative observation of interaction.

In neutralization research, the system provides a way to test whether antibodies or other inhibitors interfere with RBD-mediated interactions. Reduced interaction-associated luminescence can be compared across tested molecules or conditions to assess disruption of receptor engagement. This connects a molecular binding measurement with studies of how blocking activity may affect viral entry-related processes.